Cargando…

Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia

CONTEXT: Congenital adrenal hyperplasia (CAH) is one of the inborn errors of metabolic disorder inherited in an autosomal recessive manner caused by the defects in the steroid 21 hydroxylase CYP21A2 gene. We analyzed the genotype of 62 patients with classic CAH. AIMS: To find out the underlying muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Marumudi, Eunice, Sharma, Arundhati, Kulshreshtha, Bindu, Khadgawat, Rajesh, Khurana, Madan L., Ammini, Ariachery C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354845/
https://www.ncbi.nlm.nih.gov/pubmed/22629504
http://dx.doi.org/10.4103/2230-8210.95679
_version_ 1782233281695055872
author Marumudi, Eunice
Sharma, Arundhati
Kulshreshtha, Bindu
Khadgawat, Rajesh
Khurana, Madan L.
Ammini, Ariachery C.
author_facet Marumudi, Eunice
Sharma, Arundhati
Kulshreshtha, Bindu
Khadgawat, Rajesh
Khurana, Madan L.
Ammini, Ariachery C.
author_sort Marumudi, Eunice
collection PubMed
description CONTEXT: Congenital adrenal hyperplasia (CAH) is one of the inborn errors of metabolic disorder inherited in an autosomal recessive manner caused by the defects in the steroid 21 hydroxylase CYP21A2 gene. We analyzed the genotype of 62 patients with classic CAH. AIMS: To find out the underlying mutations of CYP21A2 gene. SETTINGS AND DESIGN: Cohort of CAH patients. MATERIALS AND METHODS: Sixty-two patients with CAH were recruited from the endocrine clinic at AIIMS. Electrochemiluminiscence method was used for estimating the levels of cortisol. Radioimmunoassay kit-based method was used for estimating the 17 OHP levels. Polymerase chain reaction amplification was done using specific primers to amply the CYP21A2 gene. STATISTICAL ANALYSIS USED: Statistical analysis was done by using Epi Info Version 3.5.1.2008. RESULTS: Out of 62 patients, 50 were simple virilizers (SV) and 12 were salt wasters (SW). Fifty-six were females and six were males. Five 46, XX children were reared as males. Age at presentation varied from 8 months to 38 years. Molecular genetic analysis revealed that the highest number of patients harboured (In 2) IVS2-13 A/C > G (48%), followed by p.P30L (46%), p.Q318X (35%), (D 8 bp) deletion 8 bp (26%), p.I172N (26%), and p. R356W (20%) mutations. CONCLUSION: This is among the few studies to analyze the mutational spectrum of CYP21A2 gene in a large CAH cohort from India. Molecular diagnosis of CYP21A2 gene should be considered as part of the CAH evaluation to assess the risk of the patients/parents/siblings and to offer genetic counseling.
format Online
Article
Text
id pubmed-3354845
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-33548452012-05-24 Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia Marumudi, Eunice Sharma, Arundhati Kulshreshtha, Bindu Khadgawat, Rajesh Khurana, Madan L. Ammini, Ariachery C. Indian J Endocrinol Metab Original Article CONTEXT: Congenital adrenal hyperplasia (CAH) is one of the inborn errors of metabolic disorder inherited in an autosomal recessive manner caused by the defects in the steroid 21 hydroxylase CYP21A2 gene. We analyzed the genotype of 62 patients with classic CAH. AIMS: To find out the underlying mutations of CYP21A2 gene. SETTINGS AND DESIGN: Cohort of CAH patients. MATERIALS AND METHODS: Sixty-two patients with CAH were recruited from the endocrine clinic at AIIMS. Electrochemiluminiscence method was used for estimating the levels of cortisol. Radioimmunoassay kit-based method was used for estimating the 17 OHP levels. Polymerase chain reaction amplification was done using specific primers to amply the CYP21A2 gene. STATISTICAL ANALYSIS USED: Statistical analysis was done by using Epi Info Version 3.5.1.2008. RESULTS: Out of 62 patients, 50 were simple virilizers (SV) and 12 were salt wasters (SW). Fifty-six were females and six were males. Five 46, XX children were reared as males. Age at presentation varied from 8 months to 38 years. Molecular genetic analysis revealed that the highest number of patients harboured (In 2) IVS2-13 A/C > G (48%), followed by p.P30L (46%), p.Q318X (35%), (D 8 bp) deletion 8 bp (26%), p.I172N (26%), and p. R356W (20%) mutations. CONCLUSION: This is among the few studies to analyze the mutational spectrum of CYP21A2 gene in a large CAH cohort from India. Molecular diagnosis of CYP21A2 gene should be considered as part of the CAH evaluation to assess the risk of the patients/parents/siblings and to offer genetic counseling. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3354845/ /pubmed/22629504 http://dx.doi.org/10.4103/2230-8210.95679 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Marumudi, Eunice
Sharma, Arundhati
Kulshreshtha, Bindu
Khadgawat, Rajesh
Khurana, Madan L.
Ammini, Ariachery C.
Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
title Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
title_full Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
title_fullStr Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
title_full_unstemmed Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
title_short Molecular genetic analysis of CYP21A2 gene in patients with congenital adrenal hyperplasia
title_sort molecular genetic analysis of cyp21a2 gene in patients with congenital adrenal hyperplasia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354845/
https://www.ncbi.nlm.nih.gov/pubmed/22629504
http://dx.doi.org/10.4103/2230-8210.95679
work_keys_str_mv AT marumudieunice moleculargeneticanalysisofcyp21a2geneinpatientswithcongenitaladrenalhyperplasia
AT sharmaarundhati moleculargeneticanalysisofcyp21a2geneinpatientswithcongenitaladrenalhyperplasia
AT kulshreshthabindu moleculargeneticanalysisofcyp21a2geneinpatientswithcongenitaladrenalhyperplasia
AT khadgawatrajesh moleculargeneticanalysisofcyp21a2geneinpatientswithcongenitaladrenalhyperplasia
AT khuranamadanl moleculargeneticanalysisofcyp21a2geneinpatientswithcongenitaladrenalhyperplasia
AT amminiariacheryc moleculargeneticanalysisofcyp21a2geneinpatientswithcongenitaladrenalhyperplasia